Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Parties to pending securities fraud class actions may adjust litigation strategies, even before the Court revisits Basic’s presumption of investor reliance. On Friday, November 15, 2013, the Supreme Court granted...more